Use of Concentrated Plasma-Derived Subcutaneous C1 Inhibitor as Long-Term Prophylaxis in an 8-Year- Old Child With Hereditary Angioedema

Lasa, E. M; Herrero, L; Martínez, S; Arruti, N; Oliver, P; Joral, A

Lasa, E. M; Herrero, L; Martínez, S; Arruti, N; Oliver, P; Joral, A.

Affiliation

Lasa, E. M; Hospital Universitario de Donostia. San Sebastián. Spain
Herrero, L; Hospital de Mendaro. Mendaro. Spain
Martínez, S; Hospital Universitario de Donostia. San Sebastián. Spain
Arruti, N; Hospital Universitario de Donostia. San Sebastián. Spain
Oliver, P; Hospital de Mendaro. Mendaro. Spain
Joral, A; Hospital Universitario de Donostia. San Sebastián. Spain

J. investig. allergol. clin. immunol ; 33(4): 302-304, 2023.

Article in English | IBECS | ID: ibc-223548

Responsible library: ES1.1

Localization: ES15.1 - BNCS

Subject(s)

Humans; Female; Child; Angioedemas, Hereditary/drug therapy; Complement C1 Inactivator Proteins; Complement Inactivating Agents; Complement C1 Inactivator Proteins/agonists; Infusions, Subcutaneous; Time Factors

C1 inhibitor deficiency; Hereditary angioedema; Children; Long-term treatment; Management; Déficit de C1 inhibidor; Angioedema hereditario; Niños; Tratamiento a largo plazo; Manejo

Fulltext

Add to My VHL

XML

Search on Google

Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Complement C1 Inactivator Proteins / Complement Inactivating Agents / Angioedemas, Hereditary Limits: Child / Female / Humans Language: English Journal: J. investig. allergol. clin. immunol Year: 2023 Document type: Article Institution/Affiliation country: Hospital Universitario de Donostia/Spain / Hospital de Mendaro/Spain

Fulltext

Add to My VHL

XML

Search on Google